Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
BioStem Technologies, Inc. (BSEM) had Income from Continuous Operations of $3.08M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$47.48M |
|
$-6.58M |
|
-- |
|
$47.48M |
|
-- |
|
$47.48M |
|
-- |
|
$47.48M |
|
$47.48M |
|
$47.48M |
|
|
Income from Continuous Operations |
$3.08M |
$3.08M |
|
$47.48M |
|
$47.48M |
|
$47.48M |
|
16.73M |
|
16.73M |
|
$-0.39 |
|
$-0.39 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
-13.86% |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|